Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

FORGOTTEN HISTORY: 4 | History Defined

Here's How Much You Would Have Made Owning McKesson Stock In The Last 5 Years

McKesson (NYSE:MCK) has outperformed the market over the past 5 years by 6.7% on an annualized basis producing an average annual return of 17.83%. Currently, McKesson has a market capitalization of $49.19 billion.

Benzinga

Why McKesson Shares Are Jumping Today

McKesson Corp (NYSE:MCK) reported Q4 FY22 adjusted EPS of $5.83, +15% Y/Y, and missing the consensus of $6.04. Revenues increased 12% Y/Y to $66.10 billion, surpassing the consensus of $63.61 billion. U.S. Pharmaceutical segment's Q4 FY22 revenues were $53.67 billion, +14%, driven by an increased volume of specialty products, including higher volumes…

Benzinga

McKesson: Q4 Earnings Insights

McKesson (NYSE:MCK) reported its Q4 earnings results on Thursday, May 5, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings McKesson missed estimated earnings by 3.48%, reporting an EPS of $5.83 versus an estimate of $6.04.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Washington, Drug Distributors Reach $518M Settlement For Opioid Claims

Washington has reached a $518 million settlement with drug distributors McKesson Corporation (NYSE:MCK), AmerisourceBergen Corp (NYSE:ABC), and Cardinal Health Inc (NYSE:CAH) to resolve opioid-related claims. Washington opted out of a $26 billion nationwide opioid settlement involving the three drug distributors and Johnson & Johnson (NYSE:JNJ). Reuters writes that it would…

Benzinga

San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters

San Francisco will start a trial against Walgreens Boots Alliance Inc (NASDAQ:WBA) and three other companies accused of fueling an opioid crisis in the city. San Francisco has alleged that Walgreens, Teva Pharmaceutical Industries Ltd (NYSE:TEVA), AbbVie Inc's (NYSE:ABBV) Allergan unit, and Teva-owned Anda Inc created a "public nuisance" by flooding the city with prescription opioids and failing…

Benzinga

President Biden To Outline Strategy To Tackle Drug Addiction, Overdose: Reuters

U.S. President Joe Biden will reveal a new strategy today for dealing with drug addiction and overdoses to expand access to medications for opioid overdoses, increase funding for law enforcement, and expand sanctions against traffickers. According to U.S. Centers For Disease Control And Prevention Data, the U.S. opioid crisis fueled more than…

Benzinga

JNJ, McKesson, Endo Settle $275M Opioid Claims With Alabama: Reuters

Alabama reached $276 million in settlements with Johnson & Johnson (NYSE:JNJ), McKesson Corporation (NYSE:MCK), and Endo International Plc (NASDAQ:ENDP), resolving claims on the opioid addiction crisis, the state attorney general said. McKesson will pay $141 million. JNJ and Endo will pay $70.3 million and $25 million, respectively, Alabama Attorney General Steve Marshall said in a statement. The three…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

5 Non-Cyclical Stocks to Buy Now if You're Worried About a Recession

As surging inflation and energy prices foster recessionary fears, it could be wise to bet on non-cyclical stocks because they tend to outperform the broader market when economic growth slows. Given the inelastic demand for their companies’ products, we think the shares of United Parcel Service (UPS), British American Tobacco…

StockNews.com

J&J's Janssen settles with WVa for $99M in opioid lawsuit

West Virginia will receive $99 million in a settlement finalized with Johnson & Johnson’s subsidiary Janssen Pharmaceuticals Inc. The state filed a lawsuit accusing the drugmaker of contributing to the opioid crisis in the state that's led the nation in overdose deaths

The Independent UK

Trial begins in West Virginia lawsuit against opioid makers

Opening arguments have taken place in a West Virginia lawsuit accusing several drugmakers of misrepresenting the risks and benefits of opioids

The Independent UK

3 Top-Rated Stocks for Value Investors to Consider

The recent stock market correction has created a few attractive opportunities for investors because many stocks are now trading at reasonable valuations. Thus, it could be wise now to invest in fundamentally solid stocks Bristol-Myers (BMY), McKesson (MCK), and AGCO (AGCO). These names are currently trading at discounts compared to…

StockNews.com

5 No-Brainer Dividend Stocks to Buy for a Recession

Multi-decade high inflation and rising energy prices have stoked recession fears. Therefore, we think investors looking to sidestep a potentially intensifying stock-market downtrend could bet on quality dividend stocks UnitedHealth (UNH), General Dynamics (GD), McKesson (MCK), Waste Connections (WCN), and AmerisourceBergen (ABC). Let’s discuss.

StockNews.com

Drug Distributors, JNJ Agree To Settle $26B Opioid Lawsuits

Distributors McKesson Corporation (NYSE: MCK), AmerisourceBergen Corp (NYSE: ABC), Cardinal Health Inc (NYSE: CAH

Benzinga

Stabilize Your Portfolio with These 5 High-Quality Stocks

The stock indices are down, heading for a second straight losing week on investor concerns about geopolitical tensions and the Fed’s actions. And the market is expected to remain volatile in the near term. Hence, we think high-quality stocks Merck & Co. (MRK), Archer-Daniels-Midland (ADM), Baxter (BAX), McKesson (MCK), and…

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Buy These 3 Stable Dividend Stocks to Protect Your Portfolio from Increased Volatility

Soaring inflation, heightened geopolitical tensions, and the Fed’s decision to raise interest rates multiple times this year have fostered severe market volatility of late. So, we think investors looking to protect their portfolios from rising volatility should consider adding quality dividend-paying stocks McKesson (MCK), AmerisourceBergen (ABC), and ORIX (IX) to…

Benzinga

Analyst Ratings For McKesson

McKesson (NYSE:MCK) has observed the following analyst ratings within the last quarter:

Benzinga

McKesson's Return on Invested Capital Insights

Pulled from Benzinga Pro data, McKesson (NYSE:MCK) showed a loss in earnings since Q2, totaling $39.00 million. Sales, on the other hand, increased by 3.06% to $68.61 billion during Q3.

Benzinga

McKesson Q3 Earnings Beat Street View, Raises FY22 Outlook Boosted By COVID-19 Vaccine Demand

McKesson Corp (NYSE: MCK) reported

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Recap: McKesson Q3 Earnings

McKesson (NYSE:MCK) reported its Q3 earnings results on Wednesday, February 2, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Benzinga

McKesson Earnings Preview

McKesson (NYSE:MCK) is set to give its latest quarterly earnings report on Wednesday, 2022-02-02. Here's what investors need to know before the announcement. Analysts estimate that McKesson will likely report an Earnings Per Share (EPS) of $5.42.

Benzinga

Wall Street Crime And Punishment: Philip Musica, The Swindler Who Could Have Been President

Does crime pay? Wall Street Crime and Punishment is a weekly series by Benzinga's Phil Hall that chronicles the bankers, brokers and financial ne’er-do-wells whose ambition and greed takes them in the wrong direction.

1 2 3 4

People

Joe Biden

68,374 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.